4
Changes in Ownership
Axsome Therapeutics, Inc. Filed Acc 0000950170-25-113311
Director sold 9,127 shares at $125.07 ($1,141,514)
- Director acquired 9,127 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Saad Mark E Director | 2025-09-05 | Option exercise 10b5-1 | +9,127 | $9.00 | $82,143 | 19,129 | D |
| Saad Mark E Director | 2025-09-05 | Sale 10b5-1 | −9,127 | $125.07 | $1,141,514 | 10,002 | D |
| Derivatives | |||||||
| Saad Mark E Director | 2025-09-05 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −9,127 | 0 | D | ||
| Open-market sales · 9,127 sh · avg $125.07 · $1,141,514 | |||||||
Loading xslF345X05/ownership.xml…